Amia Capital LLP Intra Cellular Therapies, Inc. Transaction History

Amia Capital LLP

  • $126 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$23.34 - $32.22 $466,146 - $643,497
-19,972 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$17.61 - $31.86 $99,144 - $179,371
-5,630 Reduced 21.99%
19,972 $512,000
Q2 2020

Aug 14, 2020
SELL
$14.35 - $26.64 $65,177 - $120,998
-4,542 Reduced 15.07%
25,602 $657,000
Q1 2020

May 15, 2020
BUY
$12.31 - $33.12 $371,072 - $998,369
30,144 New
30,144 $463,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.17B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Amia Capital LLP Portfolio

Follow Amia Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Amia Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email